Filter
503
Text search:
drug
approval
Featured
Recommendations
35
New Publications
116
Language
Document type
No document type
294
Studies & Reports
91
Guidelines
67
Manuals
16
Strategic & Response Plan
14
Fact sheets
12
Training Material
6
Resource Platforms
3
Countries / Regions
India
27
South Africa
18
Uganda
16
Global
16
Kenya
15
Western and Central Europe
15
Malawi
12
Ethiopia
11
Nigeria
10
Latin America and the Carribbean
9
Zimbabwe
8
Tanzania
8
Rwanda
8
Bangladesh
8
Ukraine
8
Eastern Europe
8
Ghana
7
Liberia
6
Botswana
6
Myanmar / Burma
6
South–East Asia Region
6
Sierra Leone
5
Nepal
5
Zambia
5
Africa
5
Senegal
4
Philippines
4
Cambodia
4
Namibia
4
Lesotho
4
Asia
4
Tajikistan
4
Russia
4
Thailand
3
Congo, Democratic Republic of
2
Syria
2
Bhutan
2
Venezuela
2
Burkina Faso
1
Cameroon
1
Pakistan
1
South Sudan
1
Afghanistan
1
Germany
1
Lebanon
1
China
1
Sudan
1
Benin
1
Sri Lanka
1
Yemen
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Fiji
1
Palestine
1
Albania
1
Moldova
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
201
Clinical Guidelines
43
Public Health
14
Women & Child Health
14
Key Resources
14
Pharmacy & Technologies
12
Capacity Building
3
Toolboxes
HIV
69
TB
55
AMR
39
Mental Health
31
COVID-19
31
Pharmacy
22
NTDs
13
Rapid Response
10
NCDs
10
Caregiver
8
Global Health Education
5
Planetary Health
5
Ebola & Marburg
4
Refugee
4
Malaria
4
Disability
3
Zika
3
Health Financing Toolbox
3
Polio
2
Conflict
2
Natural Hazards
2
Cholera
1
Specific Hazards
1
Social Ethics
1
2.0 Rapid Response
1
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 29.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping lab
...
10 years after the UN general assembly special session on drugs
Допомоганаркозалежнимв Україні
Довідник реабілітаційних центрів
Київ — 2014
The primary audience of these recommendations includes healthcare providers who are responsible for developing national and local health protocols (particularly those related to hypertensive disorders of pregnancy), and those directly providing care to pregnant women and their newborns, including mi
...
UN, international agencies and experts released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis.
If no action is taken - warns the UN Ad hoc Interagency Coordin
...
Training in monitoring and epidemiological assessment of mass drug administration for eliminating lymphatic filariasis: learners’ guide. World Health Organization.
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner
...
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initi
...